1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. Cannabinoid Receptor
  4. Cannabinoid Receptor Inhibitors

Cannabinoid Receptor Inhibitors

CB1

CB2

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Cannabinoid Receptor Inhibitors, Agonists, Antagonists, Activators & Modulators
Product Name CB1 CB2 Purity
Rimonabant Hydrochloride
CB1 , Ki: 1.8 nM
  99.95%
JD-5037
CB1 , IC50: 1.5 nM
  98.05%
ANEB-001
CB1
 
Pregnenolone
CB1
  98.05%
EHP-101  
CB2
98.56%
TM38837
CB1
  99.61%
N-Oleoyl glycine
CB1
  ≥99.0%
Bay 59-3074
CB1 , Ki: 48.3 nM
CB2 , Ki: 45.5 nM
99.00%
Pregnenolone monosulfate
CB1
  ≥98.0%
Leelamine
CB1
CB2
98.36%
AM281
CB1 , IC50: 9.91 nM
CB2 , IC50: 13000 nM
≥99.0%
Pregnenolone monosulfate sodium
CB1
 
Yangonin
CB1 , IC50: 1.79 μM
CB1 , Ki: 0.72 μM
  99.72%
Tedalinab  
CB2
99.94%
Leelamine hydrochloride
CB1
  98.10%
AZD1940
hCB1-R, pKi: 7.93
hCB2-R, pKi: 9.06
99.45%
GAT211
CB1
  ≥99.0%
RVD-Hpα TFA
CB1
 
Rimonabant
CB1 , Ki: 1.8 nM
 
AM9405
CB1 , IC50: 45.71 nM
 
Zevaquenabant
CB1
 
PSNCBAM-1
hCB1-R, EC50: 0.1 μM
 
(R)-SLV 319
CB1 , Ki: 894 nM
 
RTICBM-189
hCB1, pIC50: 5.29
mCB1, pIC50: 6.25
CB1 , pIC50: 7.54
  99.73%
LY320135
CB1 , Ki: 141 nM
CB2 , Ki: >10 μM
Auriculasin
CB1 , IC50: 8.92 μM
 
O-2050
CB1 , Ki: 2.5 nM
CB2 , Ki: 0.2 nM
Noladin ether
CB1 , Ki: 21.2 nM
CB2 , Ki: >3 mM
CB2 modulator 1  
CB2
Tocrifluor 1117
CB1
 
CB1R Allosteric modulator 4
hCB1-R
 
Drinabant
rCB1-R, IC50: 10 nM
hCB1-R, IC50: 25 nM
CB2 , IC50: 10000 nM
BAY 38-7271
CB1 , Ki: 1.85 nM
CB2 , Ki: 5.96 nM
CB2R-IN-1  
CB2 , Ki: 0.9 nM
CB1R Allosteric modulator 3
CB1
 
CB2 receptor agonist 2  
CB2 , Ki: 8.5 nM
PGN36  
cannabinoid type-2 receptors, Ki: 0.09 μM
CB2R PAM  
cannabinoid type-2 receptors
CB1/2 agonist 3
hCB1-R, Ki: 5.9 nM
hCB2-R, Ki: 3.5 nM
CBR Agonist-2
hCB1-R, EC50: 960 nM
hCB1-R, Ki: 970 nM
 
CB2R probe 1  
cannabinoid type-2 receptors, Ki: 130 nM
GW-405833
CB1 , EC50: 16.1 μM
CB2 , EC50: 50.7 nM
SCH 336  
hCB2-R
CB1R antagonist 1
hCB1-R, EC50: 10 μM
hCB1-R, IC50: 4.2 μM
 
2-Palmitoylglycerol
CB1
 
rel-O-2050
CB1
 
CB1/2 agonist 2
hCB1-R, Ki: 3.5 nM
hCB2-R, Ki: 1.2 nM
Ibipinabant
CB1 , Ki: 7.8 nM
CB2 , Ki: 7943 nM
N-Arachidonyldopamine
CB1 , Ki: 250 nM
 
CB1R Allosteric modulator 2
hCB1-R
 
CB1R Allosteric modulator 1
hCB1-R
 
PM226  
CB2 , EC50: 39 nM
CB2 , Ki: 13 nM
NIDA-41020
CB1 , Ki: 4.1 nM
 
RVD-Hpα
CB1
 
MJ15
rCB1-R, IC50: 118.9 pM
rCB1-R, Ki: 27.2 pM
 
Tetrahydromagnolol
CB1 , EC50: 9010 nM
CB1 , Ki: 2260 nM
CB2 , EC50: 170 nM
CB2 , Ki: 416 nM
CBR Agonist-1
rCB1-R, Ki: 0.18 μM
hCB2-R, Ki: 1.22 μM
MRL-650
CB1 , IC50: 7.5 nM
CB2 , IC50: 4100 nM
CB1/2 agonist 1
hCB1-R, EC50: 56.15 nM
cannabinoid type-2 receptors, EC50: 11.63 nM
CB1-IN-2
CB1 , IC50: 0.644 μM